Metraipolis › archive › dc_f566ff1df1b2
9,11-Dehydrocortexolone 17α-butyrate — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/9,11-Dehydrocortexolone_17%CE%B1-butyrate
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-06T21:41:38.641Z
- SHA-256 of the archived text
94273417397f43f2cad549658a028aaf156043923f9a32d8687acee93ab8eb4d- Stable URL of this page
https://metraipolis.com/documento/dc_f566ff1df1b2
How to cite
9,11-Dehydrocortexolone 17α-butyrate — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/9,11-Dehydrocortexolone_17%CE%B1-butyrate (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_f566ff1df1b2 (Metraipolis archive dc_f566ff1df1b2, sha256 94273417397f43f2cad549658a028aaf156043923f9a32d8687acee93ab8eb4d)
BibTeX
@misc{dcf566ff1df1b2,
title = {9,11-Dehydrocortexolone 17α-butyrate — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/9,11-Dehydrocortexolone_17%CE%B1-butyrate},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_f566ff1df1b2; sha256 94273417397f43f2cad549658a028aaf156043923f9a32d8687acee93ab8eb4d},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/9,11-Dehydrocortexolone_17%CE%B1-butyrate. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
9,11-Dehydrocortexolone 17α-butyrate (developmental code name CB-03-04) is a synthetic steroidal antiandrogen that was developed for use as a topical medication but was never marketed. It is the C17α butyrate (butanoate) ester of the 9,11-dehydrogenated analogue of 11-deoxycortisol (cortexolone). C17α esters of 11-deoxycortisol were unexpectedly found to possess antiandrogen activity, and 9,11-dehydrocortexolone 17α-butyrate was selected for development based on its optimum drug profile. In rats, the drug has been found to possess strong local antiandrogen activity and to also be active systemically upon subcutaneous injection. In addition, it has been found to possess antigonadotropic activity. In terms of topical antiandrogen potency, 9,11-dehydrocortexolone 17α-butyrate was found to be more potent than flutamide and finasteride and less than or equal to cyproterone acetate in potency. The drug has been suggested for possible development and medical use for the treatment of prostate cancer and benign prostatic hyperplasia. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «9,11-Dehydrocortexolone 17α-butyrate» — https://en.wikipedia.org/wiki/9,11-Dehydrocortexolone_17%CE%B1-butyrate Wikidata Q27269923: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q27269923 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/9,11-Dehydrocortexolone_17%CE%B1-butyrate?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1329024663, consultata il 2026-11-06T21:38:26.270Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: addf69f71cd47b3eef34d680cdd1ff89b0aff89199a4e8a1bc4eee07d4a0a268